Customizing adds the magic! Is Pharma making headway?
The study sheds light on the “Magic” of Multichannel Excellence. The paper provides you with insights into the vast possibilities Multichannel Excellence offers and uncovers to what extent Pharma already knows of them. The paper further explores Pharma´s status quo of MCEx and outlines what obstacles keep companies from realizing MCEx´s full potential. The reader will also learn about Camelot´s comprehensive understanding of Multichannel Excellence and receive valuable insights how to make headway adopting this integrated concept. Taylor Wessing´s deep level of legal expertise in the pharmaceutical sector has added to this comprehensive analysis of Multichannel Excellence. There are no uncontrollable legal risks relating to MCEx, but there are many options to make MCEx work. This paper is designed to pave the way for MCEx to be rolled out across the European markets.